Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2075 of 2228 entries
View as:

Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02244190 Org: User:
Start: 04/30/08 End: - Due: -

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02172781 Org: User:
Start: 01/31/01 End: - Due: -

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

Phase: N/A Priority: Normal
NCT ID: NCT03405363 Org: User:
Start: 01/31/18 End: 02/03/20 Due: 02/03/21

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Phase: N/A Priority: Normal
NCT ID: NCT00808067 Org: User:
Start: 11/30/08 End: 12/31/12 Due: 12/31/13

Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02172534 Org: User:
Start: 09/30/06 End: - Due: -

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03886272 Org: User:
Start: 04/11/19 End: 06/21/19 Due: 06/21/20

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Phase: N/A Priority: Normal
NCT ID: NCT02149108 Org: User:
Start: 09/25/14 End: 08/25/16 Due: 08/25/17

Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region

Phase: N/A Priority: Normal
NCT ID: NCT01006135 Org: User:
Start: 10/31/09 End: 06/30/11 Due: 06/30/12

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Phase: N/A Priority: Normal
NCT ID: NCT02348723 Org: User:
Start: 04/28/15 End: 11/14/16 Due: 11/14/17

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00144261 Org: User:
Start: 11/01/03 End: - Due: -

BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171676 Org: User:
Start: 05/31/05 End: - Due: -

Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02172443 Org: User:
Start: 06/30/01 End: - Due: -

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT05613036 Org: User:
Start: 01/03/23 End: 01/13/25 Due: 01/13/26

Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung

Phase: N/A Priority: Normal
NCT ID: NCT03157089 Org: User:
Start: 11/02/17 End: 01/13/20 Due: 01/13/21

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT05855109 Org: User:
Start: 11/27/23 End: 07/10/25 Due: 07/10/26

Investigation of Single Rising Doses of BI 685509

Phase: N/A Priority: Normal
NCT ID: NCT02694354 Org: User:
Start: 03/31/16 End: 04/30/16 Due: 04/30/17

Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183259 Org: User:
Start: 11/30/98 End: - Due: -

SPIRIVA in Ususal Care

Phase: N/A Priority: Normal
NCT ID: NCT00274079 Org: User:
Start: 10/31/02 End: 10/31/03 Due: 10/31/04

Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02191176 Org: User:
Start: 06/30/09 End: - Due: -

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT02244346 Org: User:
Start: 05/31/04 End: - Due: -

The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04206787 Org: User:
Start: 05/20/20 End: 12/22/23 Due: 12/22/24

A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04099732 Org: User:
Start: 10/07/19 End: 12/10/19 Due: 12/10/20

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Phase: N/A Priority: Normal
NCT ID: NCT05536791 Org: User:
Start: 11/24/22 End: 10/01/24 Due: 10/01/25

Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00726479 Org: User:
Start: 08/31/08 End: - Due: -

Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT01911780 Org: User:
Start: 07/31/13 End: 01/31/15 Due: 01/31/16